Envista Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 02, 2023 at 04:10 pm EDT
Share
Envista Holdings Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 662.4 million compared to USD 645.8 million a year ago. Net income was USD 51.9 million compared to USD 47.1 million a year ago. Basic earnings per share from continuing operations was USD 0.32 compared to USD 0.27 a year ago. Diluted earnings per share from continuing operations was USD 0.29 compared to USD 0.25 a year ago. Basic earnings per share was USD 0.32 compared to USD 0.29 a year ago. Diluted earnings per share was USD 0.29 compared to USD 0.26 a year ago.
For the six months, sales was USD 1,289.6 million compared to USD 1,277.2 million a year ago. Net income was USD 95.7 million compared to USD 122 million a year ago. Basic earnings per share from continuing operations was USD 0.58 compared to USD 0.71 a year ago. Diluted earnings per share from continuing operations was USD 0.54 compared to USD 0.64 a year ago. Basic earnings per share was USD 0.58 compared to USD 0.75 a year ago. Diluted earnings per share was USD 0.54 compared to USD 0.68 a year ago.
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.